BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36572597)

  • 1. Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis.
    Lin TW; Hu YC; Chiang BL
    J Microbiol Immunol Infect; 2023 Apr; 56(2):416-423. PubMed ID: 36572597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
    Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
    Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
    Rajarathinam I; Raghuram J; Rao AP
    Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
    Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
    Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK; Yang YH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes.
    Sun C; Lee JH; Yang YH; Yu HH; Wang LC; Lin YT; Chiang BL
    Pediatr Neonatol; 2015 Feb; 56(1):31-9. PubMed ID: 24985888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile dermatomyositis: a tertiary center experience.
    Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
    Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
    Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.
    Malek A; Raeeskarami SR; Ziaee V; Aghighi Y; Moradinejad MH
    Clin Rheumatol; 2014 Aug; 33(8):1113-8. PubMed ID: 24878926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
    Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
    Prasad S; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study.
    Faller G; Mistry BJ; Tikly M
    Pediatr Rheumatol Online J; 2014 Jan; 12():2. PubMed ID: 24397895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Juvenile dermatomyositis: A series of 22 cases].
    Moegle C; Lipsker D
    Ann Dermatol Venereol; 2020 Sep; 147(8-9):494-503. PubMed ID: 32532518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis.
    Gezgin Yıldırım D; Baglan E; Güngörer V; Yıldız C; Tuncez S; Bülbül M; Acar B; Bakkaloğlu SA
    Int J Rheum Dis; 2023 Aug; 26(8):1504-1511. PubMed ID: 37288472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease patterns of juvenile dermatomyositis from Western India.
    Chickermane PR; Mankad D; Khubchandani RP
    Indian Pediatr; 2013 Oct; 50(10):961-3. PubMed ID: 23798628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.
    McCann LJ; Juggins AD; Maillard SM; Wedderburn LR; Davidson JE; Murray KJ; Pilkington CA;
    Rheumatology (Oxford); 2006 Oct; 45(10):1255-60. PubMed ID: 16567354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients.
    Karaca Ö; Güngör M; Sakarya Güneş A; Eser Şimşek I; Anık Y; Kara B
    Int J Rheum Dis; 2022 May; 25(5):617-625. PubMed ID: 35238477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature.
    Sener S; Basaran O; Batu ED; Sag E; Oz S; Talim B; Bilginer Y; Haliloglu G; Ozen S
    Semin Arthritis Rheum; 2023 Feb; 58():152133. PubMed ID: 36434896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.